Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D002273:Carcinogens; D003352:Corynebacterium; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007167:Immunotherapy; D007938:Leukemia / Q000276:immunology / Q000628:therapy; D008264:Macrophages / Q000276:immunology; D009161:Mycobacterium; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D009374:Neoplasms, Experimental; D009858:Oncogenic Viruses; D011119:Polynucleotides / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002273:Carcinogens; D011119:Polynucleotides